Can the HPV vaccine stop young women from dying of cervical cancer?
Yes. In England, the HPV vaccine drove cervical cancer deaths down to zero among women aged 20 to 24 between 2020 and 2024, the first time that has ever happened on record. Without the vaccine, researchers estimate about 23 of these young women would have died.
This finding comes from a large study that tracked cervical cancer deaths across England from 2001 to 2024. The women who reached their early twenties death-free were part of a group with very high HPV vaccine coverage, near 90 percent. For the first time, an entire age group passed through these years without losing a single young woman to this cancer.
What the data show
The numbers tell a powerful story. Among women aged 20 to 24, the expected toll of roughly 23 deaths simply did not appear. Instead, that count dropped to zero. The researchers connect this directly to the HPV vaccine, which protects against the virus that causes nearly all cervical cancers.
The benefit reaches further than one age group. The study estimates that children vaccinated at age 12 or 13 now have a near-zero risk of dying from cervical cancer before age 30. Looking back at the bigger picture, the school-based HPV vaccine program that England started in 2008 has already prevented nearly 200 young women from dying of the disease.
Dr. Kumar’s Take
This is one of the most encouraging cancer findings I have seen in years. We have known for a long time that the HPV vaccine prevents infections and precancers. What is new here is real-world proof, at the level of an entire country, that it prevents deaths. Zero deaths in a whole age group is not a statistical trick. It is mothers, daughters, and sisters who are alive because of a vaccine given in school.
I want to be honest about the limits too. This study looks at deaths in young women, so the very long-term picture into later decades is still being written. But the direction is clear, and it is hard to overstate how meaningful that is for a cancer that once killed thousands.
How the disease starts and how the vaccine helps
Almost all cervical cancers are caused by HPV, a common virus spread through skin contact. In most people the body clears it, but in some it lingers and slowly damages cells in the cervix over many years. That slow path is why catching the virus early, before it ever takes hold, matters so much.
The HPV vaccine works by teaching the immune system to block the virus before it can infect those cells. Giving it at age 12 or 13, before most people are exposed, offers the strongest protection. England built this into its schools in 2008, and this study shows that decision now paying off in lives saved.
Why this matters beyond England
England’s experience acts like a real-world test of what widespread vaccination can do. Many countries run similar school-based programs, and these results suggest they can expect the same kind of steep drop in deaths as their vaccinated children grow up. It also strengthens the case for reaching high coverage, since the strongest results here came from a group where nearly 90 percent were protected.
The message for families is simple and hopeful. A vaccine given to a child can take a deadly cancer off the table decades later. Few prevention tools in medicine work that cleanly.
Practical Takeaways
- If you have a child around age 11 to 13, talk to your doctor about the HPV vaccine, since the strongest protection comes from vaccinating before any exposure to the virus.
- Older teens and young adults who missed the shot can often still catch up, so ask your provider whether you or your family members are eligible.
- Vaccination does not replace cervical screening, so keep up with recommended Pap and HPV tests as you get older to catch any problems early.
- Aim for the full recommended vaccine schedule, because the dramatic results in this study came from communities with very high coverage.
Related Studies and Research
- The HPV vaccine cuts cancer risk in boys and young men by nearly half
- Shingles vaccine cuts heart attack risk nearly in half for heart disease patients
- Insomnia plus sleep apnea raises heart disease risk nearly 4-fold
- Your favorite music helps you exercise nearly 20 percent longer
FAQs
At what age should my child get the HPV vaccine?
Most health programs recommend the HPV vaccine around age 11 to 13, and England gives it through schools at age 12 or 13. The reason is timing. The vaccine works best when given before any contact with the virus, which usually means before someone becomes sexually active. In this study, the children vaccinated at that age were estimated to have a near-zero risk of dying from cervical cancer before age 30. If your child is older and missed it, ask your doctor, because catch-up vaccination is often still possible and worthwhile.
Do vaccinated women still need cervical cancer screening?
Yes. The HPV vaccine protects against the virus types responsible for most cervical cancers, but it does not cover every type, and not everyone was vaccinated before exposure. Screening tests like the Pap smear and HPV test can find early changes in cervical cells before they ever turn into cancer. Think of the vaccine and screening as two layers of protection that work better together. Skipping screening just because you were vaccinated leaves a gap that is easy to avoid.
How do we know the vaccine caused the drop in deaths and not something else?
This study is strong because it follows population-level data across England over more than two decades, from 2001 to 2024. That long timeline lets researchers compare what actually happened with what would have been expected without vaccination, which was about 23 deaths in the youngest group. The zero deaths appeared specifically in the age group with very high vaccine coverage, near 90 percent. That close match between who was protected and who survived is what makes the link convincing, though scientists will keep tracking these women as they age.
Bottom Line
For the first time on record, an entire age group of young women in England, those aged 20 to 24, passed through these years without a single death from cervical cancer. This happened in a group with HPV vaccine coverage near 90 percent, where about 23 deaths would otherwise have been expected. Combined with the nearly 200 lives the school program has saved since 2008, these results offer real-world proof that the HPV vaccine is turning a once-deadly cancer into one young women rarely die from.
